Sosei Heptares Turns To AI In GPCR-Focused Drug Discovery Pact

Duo Is Using AI To Identify GPCR Targets Across Multiple Disease Areas

 
• By Sten Stovall
  
It is the first time that Sosei has used AI to identify new drug targets. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip